3 transcripts
URGN
Earnings call transcript
NASDAQ
2024 Q2
13 Aug 24
risk of progression. This condition is essentially chronic, necessitating long-term monitoring and management. The current standard of care
URGN
Earnings call transcript
NASDAQ
2024 Q1
13 May 24
of this chronically recurrent patient population.
Nonetheless, this 50% number was our projection. As you noted, the data we've provided from our
URGN
Earnings call transcript
NASDAQ
2023 Q4
14 Mar 24
and others say on many occasions, our experience in that others is that this is a chronically relapsing illness, which is why [Audio Gap] to surgical
- Prev
- 1
- Next